Transgenic transchromosomal rodents for making human antibodies
US9426970B2 · kind B2 · utility
2Cited by
36References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 24, 2014 |
| Grant date | Aug 30, 2016 |
| Priority date | — |
| Expiry date | Jul 24, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel transgenic nonhuman mammals capable of producing human sequence antibodies, as well as methods of producing and using these antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.